Trial Profile
Efficacy and safety of Entecavir/PEG-IFN-alpha sequential therapy for chronic active hepatitis B
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 08 Jan 2020
Price :
$35
*
At a glance
- Drugs Entecavir (Primary) ; Peginterferon alfa
- Indications Hepatitis B
- Focus Therapeutic Use
- Acronyms B-SHOOT
- 01 Apr 2015 New trial record